Cue Biopharma falls 25% despite 1-for-30 reverse split plan
Summary
Cue Biopharma (CUE) plans a 1-for-30 reverse stock split April 23 to meet Nasdaq rules; shares, options adjust and no fractional shares.
Description
Cue Biopharma (CUE) plans a 1-for-30 reverse stock split April 23 to meet Nasdaq rules; shares, options adjust and no fractional shares.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source